Mirum Pharmaceuticals, Inc. shows strong growth with a 43% revenue jump and promising pipeline assets. Click here for my ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

AIM Vaccine Co., Ltd. Class H ( ($HK:6660) ) has provided an update. AIM Vaccine Co., Ltd. has received approval from the U.S. FDA to conduct ...

Wedbush initiated coverage on Zenas BioPharma, Inc. (NASDAQ:ZBIO), a clinical-stage global biopharmaceutical company focused ...

New presidential approval rating polls are being released, reflecting public opinion on the first 50 days of President Donald Trump's second term. Factors such as the state of the economy ...

The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...

This weekend, the FDA announced that two types of Savage Pet raw cat food are being recalled for potential contamination with ...

Alnylam Pharma (ALNY) stock rocketed higher on Friday after the pharmaceutical company received approval from the U.S. Food and Drug ...

President Trump's approval rating averages around 46% since taking office for his second term, with a range of 34%-49% throughout his presidency. This rating is higher than his first term average ...

According to the most recent Gallup poll, Trump's job approval rating was averaging 46% since he took office in this second term. His first term overall average was a 41% approval rating.

The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for adult patients with moderately to severely active ...